Roy Helmy, PhD
Research Fellow, Merck & Co. Inc.
Articles by Roy Helmy, PhD
Sin categorizar
Two Options for Analyzing Potential Genotoxic Impurities in Active Pharmaceutical Ingredients
23 Oct 2020
